Skip to content

CHECK OUT OUR FEATURED SPEAKERS FOR THIS YEAR’S EVENT

This event is invite only

Call for Abstracts: Avicanna’s 5th Medical Symposium on Cannabinoid-Based Medicine

June 6th, 2025 | Toronto, Canada

We invite abstract submissions for poster presentations that highlight original research, clinical experiences, and forward-thinking innovations across the cannabinoid medicine spectrum.

Submission Guidelines

  • Abstract Length: 250–300 words (excluding title/authors)
  • Format:
    • Abstracts must be structured into five sections: Title, Rationale, Methods, Results, and Conclusions
    • The maximum word count is 300 words, excluding title, authors, affiliations, and funding sources
    • Include funding sources, abbreviations, and references (Note: These will not count towards the final word count)
    • Institutional information must be provided for all authors
    • Figures, tables, and other illustrations are not permitted in the submission
    • Data previously presented at other meetings is eligible for consideration
    • Posters must be submitted by one of the study authors or investigators; third-party submissions will not be accepted
  • Deadline: April 28, 2025 (11:59 PM EST)
  • Eligibility: Open to researchers, clinicians, policymakers, and industry experts
  • Review Process: Peer-reviewed for scientific merit, innovation, and relevance
  • Notification of Acceptance: May 9, 2025, by 5:00 PM EST

Submit your abstract via our online form

SUBMIT NOW
Accepted presenters will receive poster guidelines, assigned display location, and onsite logistics ahead of the event. For inquiries, an Avicanna team member will be available to support you throughout the process.
Join the conversation. Shape the future of cannabinoid-based care. Submit your abstract today!

THANK YOU TO EVERYONE WHO JOINED US AT LAST YEAR’S EVENT

We had the pleasure of hosting our 4th annual medical symposium, where attendees had the opportunity to join medical professionals and industry leaders presenting the latest advancements in medical cannabis.

The videos below showcase all the compelling presentations and panel discussions on the various of topics that were presented throughout the four sessions.

1. Real World Evidence Studies
2. Access to Medical Cannabis
3. Clinical Application
4. Concluding Session

Opening Remarks

Aras Azadian
Avicanna

The Evolution of Medical Cannabis and Canada’s Leadership

Session 1: Real-World Evidence Studies

Dr. Camila Sofia Arriagada Egnen
Hospital for Sick Children

Evaluating a Cannabidiol Cream in Children with Epidermolysis Bullosa

Dr. Karolina Urban
Avicanna

Results of a Prospective Real-world Evidence Study in Patients with Localized Musculoskeletal Pain and Inflammation

Dr. Hance Clarke (University Health Network), Erin Prosk (Sante Cannabis)

The Role and Benefits of Real-world Evidence Studies in Understanding the Potential Therapeutic Benefits of Cannabinoids

Session 2: Access to Medical Cannabis

Samantha Aitken
MyMedi.ca

Introduction to MyMedi.ca’s Medical Cannabis Care Platform

Dr. Carlo De Angelis
Sunnybrook Health Sciences Centre

Pharmacist Led Cannabis Consultation Service for Sunnybrook Odette Cancer Patients: A Case Study in Meeting Patient Needs

Dr. Carlo De Angelis (Sunnybrook Health Sciences Centre)
Blake Pearson (Pearson Health)
Cristina Montoya (Arthritis Society Patient Advocate)

A Patient’s Perspective and Ongoing Challenges with Patient Access

Session 3: Clinical Application

Dr. Alan Bell
University of Toronto

Clinical Practice Guidelines for Chronic Pain & Co-occurring Conditions

Dr. Hance Clarke
University Health Network

Clinical Practice Guidelines for Chronic Pain & Co-occurring Conditions

Dr. Evan Lewis
Neurology Centre of Toronto

Use of Cannabinoids in Pediatric Refractory Epilepsy Patients

Dr.Alan Bell (University of Toronto)
Dr. Hance Clarke (University Health Network)
Dr. Evan Lewis (Neurology Centre of Toronto)

The Challenges with Establishing Medical Cannabis Treatment Plans for Patients

Session 4: Concluding Session

Dr. Tania Di Renna
Women’s Health College, Toronto Academic Pain Medicine Institute

The Potential Role of Cannabinoid-based Medicines in Women’s Health

Aras Azadian (Avicanna)
Keith Strachan (Medipharm Labs)
Andrew Bevan (Canopy Growth)
Dr. Julia Hoeng (Vectura Fertin Pharma)

The Role of Industry in Advancing Cannabis-based Medicine ​

If you are a Healthcare Provider and would like more information, contact us at info@avicanna.com.